Profile
Shi Gao Liu is the founder of two companies, Henlius Biopharmaceuticals, Inc. and Shanghai Henlius Biotech, Inc., both founded in 2009.
He held the title of President & Chief Executive Officer at Henlius Biopharmaceuticals, Inc. and Chief Executive Office & Executive Director at Shanghai Henlius Biotech, Inc. Dr. Liu received a doctorate degree from Purdue University in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 2,410,695 ( 1.48% ) | 4 M $ | 2024-03-30 |
Former positions of Shi Gao Liu
| Companies | Position | End |
|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Founder | 2020-09-29 |
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Chief Executive Officer | - |
Training of Shi Gao Liu
| Purdue University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Stock Market
- Insiders
- Shi Gao Liu
